Fundraising FoxImmuto Scientific
5 known investors
Find your way into Immuto Scientific
Each arrow is one introduction. Sign up to fill in the first one.
Ask Dale Willis to introduce you to Daniel Benjamin
You →Dale · together at Extreme Engineering Solutions →Daniel
Ask Jamie Chen to introduce you to Faraz A Choudhury
You →Jamie · together at Lawrence University →Faraz
Sign up to find every way you can get introduced to Immuto Scientific
- Your email: who you already know at Immuto Scientific, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Immuto Scientific team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Immuto Scientific uses patient-derived tissue models combined with computational structural proteomics and machine learning to identify disease-specific protein targets for drug discovery. The platform applies advanced mass spectrometry and molecular simulations to distinguish diseased from healthy tissues and accelerate therapeutic development.
Founders & leadership
Investors · 5
How we know: DYDX Capital's portfolio page · Not right? Tell us
How we know: Great Oaks Venture Capital's portfolio page · Not right? Tell us
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $1.9M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $321.8K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Immuto Scientific do?
- Immuto Scientific uses patient-derived tissue models combined with computational structural proteomics and machine learning to identify disease-specific protein targets for drug discovery. The platform applies advanced mass spectrometry and molecular simulations to distinguish diseased from healthy tissues and accelerate therapeutic development.
- Who founded Immuto Scientific?
- Immuto Scientific was founded by Faraz A Choudhury, Daniel Benjamin.
- Who are Immuto Scientific's investors?
- Immuto Scientific's investors include DYDX Capital, Great Oaks Venture Capital, Tundra Angels, Venture Management, Wisconsin Investment Partners.